Clinical Trials Directory

Trials / Completed

CompletedNCT02218138

Learning to BREATHE: A Randomized Controlled Trial to Lower Diabetes Risk in Adolescent Girls

Depression and Insulin Resistance in Adolescents

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Colorado State University · Academic / Other
Sex
Female
Age
12 Years – 17 Years
Healthy volunteers
Accepted

Summary

Type 2 diabetes is a chronic disease that puts people at risk for major health problems like heart disease. Type 2 diabetes is the most common type of diabetes in adults. However, there has been a concerning rise in type 2 diabetes among teenagers. Diabetes develops through poor insulin sensitivity, meaning that insulin - an important chemical the body makes to keep blood sugar normal - isn't working properly. Type 2 diabetes can be prevented by improving insulin sensitivity. Stress is related to insulin sensitivity. Individuals who feel stressed have worse insulin sensitivity than individuals who do not feel stressed. In adults, decreasing stress leads to improvements in insulin sensitivity, but this hasn't been tested in teenagers. The purpose of this study is to find out if taking part in a brief group program to decrease stress will improve insulin sensitivity and lower diabetes risk in teenage girls.

Detailed description

After a screening to determine eligibility, girls are randomly assigned to take part in one of two 6-week group programs: 1) Learning to BREATHE - a mindfulness-based program, or 2) Colorado Blues - a cognitive-behavioral program. After the group, girls return for three follow-up visits over the course of a year. The main outcomes are depressive symptoms and insulin resistance. We also are assessing stress, eating behavior, fitness, and mindfulness.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLearning 2 BREATHEMindfulness-based group program
BEHAVIORALColorado BluesColorado Blues, Cognitive-behavioral depression prevention group

Timeline

Start date
2013-01-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2014-08-15
Last updated
2020-03-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02218138. Inclusion in this directory is not an endorsement.